Researchers determined the association between obesity and the risk for incident gout, according to genetic predisposition, in individuals aged greater than 32 years, stratified by sex.
Investigators used dual-energy computed tomography to assess the extent of spinal monosodium urate deposition among patients with gout.
Researchers studied the comparative efficacy and safety of urate-lowering therapy – allopurinol vs febuxostat – in the treatment of gout.
Researchers compared the beneficial effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on gout risk in patients with type 2 diabetes.
The EULAR/ERA-EDTA developed updated recommendations for the management of lupus nephritis.
Researchers sought to understand the unmet needs for patients and provide insight into achieving better treatment for gout.
Researchers determined the effect of serum urate-associated genetic variants on gout risk in individuals receiving diuretics vs those who were not.
Researchers assessed changes in the estimated glomerular filtration rate among patients with gout with moderate renal impairment, using a treat-to-target approach for gout.
Researchers assessed the criteria for gout remission and defined the criteria for a complete response in patients with chronic refractory gout.
Researchers compared the effectiveness and safety of naproxen with low-dose colchicine in the treatment of gout flares in primary care.
